Alpine Global Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Alpine Global Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-27,509	Closed	-$142K	–	115
2019 Q2	$142K	Buy	+27,509	New	+$124K	0.04%	59

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Alpine Global Management's PETX Position: Q3 2019 in Review

Alpine Global Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 27,509 shares — an estimated $142K sold.

Alpine Global Management first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $142K in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Alpine Global Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Alpine Global Management sold 27,509 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $142K.
Alpine Global Management first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Alpine Global Management's Aratana Therapeutics, Inc. position peaked at $142K in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Alpine Global Management's 13F filing for Q3 2019, filed 11 Oct 2019.